The HemOnc Pulse Discussing the Role of MRD in CLL With Talal Hilal, MD
May 16, 2024
Dr. Talal Hilal from Mayo Clinic discusses measuring MRD in CLL with Chadi Nabhan. They explore MRD detection methods, its role in treatment decisions, challenges with doublet therapies, and the controversy around MRD in CLL.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 3min
Evolving Measurement of Minimal Residual Disease in Cancer Treatment
02:46 • 3min
Exploring the Impact of MRD in CLL Treatment
06:00 • 9min
Challenges of Doublet Therapies Approval and MRD-guided Treatment Decisions in CLL
14:31 • 2min
Navigating the MRD Controversy in CLL
16:05 • 5min